Cesca Therapeutics PE Ratio 2006-2019 | KOOL

Current and historical p/e ratio for Cesca Therapeutics (KOOL) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cesca Therapeutics PE ratio as of September 20, 2019 is 0.00.
Cesca Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-09-20 5.33 0.00
2019-06-30 2.81 $-3.97 0.00
2019-03-31 0.29 $-20.80 0.00
2018-12-31 0.27 $-22.70 0.00
2018-09-30 0.32 $-21.20 0.00
2018-06-30 0.42 $-22.40 0.00
2018-03-31 2.01 $-5.20 0.00
2017-12-31 3.00 $-4.60 0.00
2017-09-30 3.56 $-8.10 0.00
2017-06-30 3.17 $-42.80 0.00
2017-03-31 3.25 $-42.70 0.00
2016-12-31 3.45 $-80.60 0.00
2016-09-30 3.92 $-81.10 0.00
2016-06-30 2.93 $-60.00 0.00
2016-03-31 3.88 $-60.00 0.00
2015-12-31 3.64 $-44.00 0.00
2015-09-30 10.60 $-62.00 0.00
2015-06-30 17.00 $-62.00 0.00
2015-03-31 18.00 $-62.00 0.00
2014-12-31 20.40 $-52.00 0.00
2014-09-30 24.40 $-50.00 0.00
2014-06-30 27.80 $-62.00 0.00
2014-03-31 34.00 $-62.00 0.00
2013-12-31 20.40 $-62.00 0.00
2013-09-30 21.60 $-48.00 0.00
2013-06-30 27.00 $-8.00 0.00
2013-03-31 17.00 $-8.00 0.00
2012-12-31 16.80 $-16.00 0.00
2012-09-30 20.60 $-26.00 0.00
2012-06-30 19.00 $-52.00 0.00
2012-03-31 17.80 $-52.00 0.00
2011-12-31 14.20 $-42.00 0.00
2011-09-30 24.80 $-32.00 0.00
2011-06-30 40.20 $-18.00 0.00
2011-03-31 41.80 $-18.00 0.00
2010-12-31 70.40 $-22.00 0.00
2010-09-30 57.80 $-40.00 0.00
2010-06-30 38.95 $-72.00 0.00
2010-03-31 56.00 $-72.00 0.00
2009-12-31 46.15 $-72.00 0.00
2009-09-30 49.60 $-72.00 0.00
2009-06-30 50.40 $-80.00 0.00
2009-03-31 49.60 $-80.00 0.00
2008-12-31 34.40 $-104.00 0.00
2008-09-30 100.00 $-104.00 0.00
2008-06-30 112.00 $-96.00 0.00
2008-03-31 130.40 $-96.00 0.00
2007-12-31 126.40 $-72.00 0.00
2007-09-30 178.40 $-80.00 0.00
2007-06-30 220.80 $-64.00 0.00
2007-03-31 291.20 $-64.00 0.00
2006-12-31 344.80 $-64.00 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.011B $0.010B
Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation, processing and preservation of cell and tissue therapy products. The Company sells its products in approximately 30 countries throughout the world to customers that include private and public cord blood banks, surgeons, hospitals and research institutions. Cesca Therapeutics Inc., formerly known as ThermoGenesis Corp., is headquartered in Rancho Cordova, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $118.124B 25.17
Intuitive Surgical (ISRG) United States $61.173B 53.51
Edwards Lifesciences (EW) United States $45.304B 44.10
IDEXX Laboratories (IDXX) United States $23.479B 58.90
Fresenius Medical Care AG KGaA (FMS) Germany $21.107B 14.17
Olympus (OCPNY) Japan $17.550B 131.79
Teleflex (TFX) United States $15.758B 33.45
DexCom (DXCM) United States $14.310B 212.07
SONOVA HOLDING (SONVY) Switzerland $14.266B 0.00
Sysmex ADR (SSMXY) Japan $14.060B 37.90
Hologic (HOLX) United States $13.363B 21.09
STERIS (STE) Ireland $12.232B 28.21
Varian Medical Systems (VAR) United States $10.694B 25.59
ABIOMED (ABMD) United States $8.652B 49.53
Masimo (MASI) United States $8.125B 49.30
SARTORIUS AG (SARTF) Germany $5.614B 49.88
Penumbra (PEN) United States $5.222B 187.60
Integra LifeSciences Holdings (IART) United States $5.218B 23.28
Globus Medical (GMED) United States $5.070B 32.18
Elekta AB (EKTAY) Sweden $5.005B 38.53
LivaNova (LIVN) United Kingdom $3.834B 29.24
Cantel Medical (CMD) United States $3.767B 38.22
Tandem Diabetes Care (TNDM) United States $3.589B 0.00
Nevro (NVRO) United States $2.733B 0.00
Wright Medical Group (WMGI) Netherlands $2.673B 234.44
Glaukos (GKOS) United States $2.666B 0.00
Integer Holdings (ITGR) United States $2.589B 18.32
Nihon Kohden (NHNKY) Japan $2.483B 24.98
AVANOS MEDICAL, INC (AVNS) United States $1.734B 32.16
OPKO Health (OPK) United States $1.293B 0.00
Veracyte (VCYT) United States $1.257B 0.00
Accelerate Diagnostics (AXDX) United States $1.164B 0.00
CryoLife (CRY) United States $1.100B 104.75
Silk Road Medical (SILK) United States $1.087B 0.00
Inogen (INGN) United States $1.063B 26.05
Natus Medical (NTUS) United States $1.060B 24.70
Luminex (LMNX) United States $0.996B 0.00
Mesa Laboratories (MLAB) United States $0.973B 44.95
Tactile Systems Technology (TCMD) United States $0.965B 119.23
ORTHOFIX MEDICAL INC (OFIX) United States $0.965B 30.30
Corindus Vascular Robotics (CVRS) United States $0.885B 0.00
Pacific Biosciences Of California (PACB) United States $0.837B 0.00
AngioDynamics (ANGO) United States $0.694B 22.61
OrthoPediatrics (KIDS) United States $0.576B 0.00
Intersect ENT (XENT) United States $0.570B 0.00
Quotient (QTNT) Switzerland $0.556B 0.00
AxoGen (AXGN) United States $0.549B 0.00
Si-Bone (SIBN) United States $0.486B 0.00
Fluidigm (FLDM) United States $0.391B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.381B 14.64
ViewRay (VRAY) United States $0.353B 0.00
Alphatec Holdings (ATEC) United States $0.342B 0.00
Sientra (SIEN) United States $0.339B 0.00
GenMark Diagnostics (GNMK) United States $0.338B 0.00
Semler Scientific (SMLR) United States $0.294B 49.45
Stereotaxis (STXS) United States $0.290B 0.00
Accuray (ARAY) United States $0.259B 0.00
IRadimed (IRMD) United States $0.249B 41.38
RTI Surgical (RTIX) United States $0.234B 35.11
SeaSpine Holdings (SPNE) United States $0.233B 0.00
CRH Medical (CRHM) Canada $0.215B 74.50
Neuronetics (STIM) United States $0.203B 0.00
TransEnterix (TRXC) United States $0.157B 0.00
ConforMIS (CFMS) United States $0.137B 0.00
EDAP TMS S.A (EDAP) France $0.128B 63.00
Second Sight Medical Products (EYES) United States $0.119B 0.00
T2 Biosystems (TTOO) United States $0.114B 0.00
Sensus Healthcare (SRTS) United States $0.104B 0.00
Spectral Diagnostics (EDTXF) Canada $0.075B 0.00
Apollo Endosurgery (APEN) United States $0.069B 0.00
Vermillion (VRML) United States $0.054B 0.00
Electromed (ELMD) United States $0.052B 26.74
Helius Medical Technologies (HSDT) United States $0.045B 0.00
Ekso Bionics Holdings (EKSO) United States $0.040B 0.00
Bioanalytical Systems (BASI) United States $0.038B 0.00
Xtant Medical Holdings (XTNT) United States $0.032B 0.00
Neovasc (NVCN) Canada $0.031B 0.00
Nuvectra (NVTR) United States $0.027B 0.00
Restoration Robotics (HAIR) United States $0.027B 0.00
ReWalk Robotics (RWLK) Israel $0.023B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.023B 0.00
Ra Medical Systems (RMED) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.015B 21.58
Lianluo Smart (LLIT) China $0.013B 0.00
OBALON THERPTCS (OBLN) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.011B 0.00
Dynatronics (DYNT) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.008B 0.00
Avinger (AVGR) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Micron Solutions (MICR) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Viveve Medical (VIVE) United States $0.004B 0.00